# Hospital at Home at EOL in Heme Malignancies

> **NCT04690205** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 72 (actual)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **OTHER:** End of Life (EOL) Care at at Home

## Key facts

- **NCT ID:** NCT04690205
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-26
- **Primary completion:** 2024-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04690205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04690205, "Hospital at Home at EOL in Heme Malignancies". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04690205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*